NHS ENGLAND
Buyer information published with procurement notices.
- Published identifier
- GB-PPON PDPT-3135-BWWY
- Address
- London, UKI45, SE1 8UG, United Kingdom
- First notice
- 30 Jan 2025
- Latest notice
- 22 Oct 2026
Published procurement activity · 1,388 tenders
Buyer information published with procurement notices.
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strategic aims of growing and transforming the workforce to meet service demand in line with Long Term Workforce Plan and 10 Year Plan ambitions.
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strategic aims of growing and transforming the workforce to meet service demand in line with Long Term Workforce Plan and 10 Year Plan ambitions.
This is a Provider Selection Regime (PSR) contract modification notice, under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally modified under Reg 13(1)(d) of PS
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strategic aims of growing and transforming the workforce to meet service demand in line with Long Term Workforce Plan and 10 Year Plan ambitions.
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strategic aims of growing and transforming the workforce to meet service demand in line with Long Term Workforce Plan and 10 Year Plan ambitions.
This is the routine surveillance of Prostate-Specific Antigen (PSA) for men who are at higher risk of prostate cancer.
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strategic aims of growing and transforming the workforce to meet service demand in line with Long Term Workforce Plan and 10 Year Plan ambitions.
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strategic aims of growing and transforming the workforce to meet service demand in line with Long Term Workforce Plan and 10 Year Plan ambitions.
Preliminary market consultation to inform the NHS commercial strategy for Technologies that sample abnormal cells in the oesophagus. Please note all stated financial values in relation to this notice are nominal, as the financial envelope is yet to be defined. Projected contracting dates in the notice, similarly do not reflect a
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strategic aims of growing and transforming the workforce to meet service demand in line with Long Term Workforce Plan and 10 Year Plan ambitions.
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.